miR-34a also increases sensitivity to conventional chemotherapy by directly targeting cancer stemness-related protein, NOTCH1 (11) or GOLPH3 (12), as well as inhibits 53BP1-mediated DNA damage repair (13) in different cancers. This evidence concerns the gene TP53BP1 and cancer.